Imatinb Mesylate
Online Inquiry
| CAT# | Z10-101-141 |
| CAS | 220127-57-1 |
| Synonyms/Alias | GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE;CGP-57148B;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;STI-571;IMATINIB BASE(IMA-3) |
| M.F/Formula | C30H35N7O4S |
| M.W/Mr. | 589.71 |
| Application | A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which i |
Write a review
Ask a question
My Review for Imatinb Mesylate
Required fields are marked with *
×
Ask a Question for Imatinb Mesylate
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
